Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.As scientists race to develop vaccines and treatments for COVID-19, Democrats in Congress have renewed their push for price controls on drugs designed to protect us from the respiratory disease caused by the coronavirus, along with other illnesses.The Democrats claim many Americans will only be able to afford the therapies that emerge if the government caps their prices.But price controls are a counterproductive way to bring down the cost of vaccines and drugs to treat diseases. They’d not only result in shortages but also make it harder for researchers to develop lifesaving drugs.By contrast, injecting transparency into the pharmaceutical market at home and negotiating better trade deals abroad would yield lower drug prices without jeopardizing medical progress.CORONAVIRUS SICKENING YOUNG ADULTS, CHILDREN: WE ARE LEARNING ‘THAT EVERYONE IS AT RISK’Congressional Democrats have been doing their best not to let this crisis go to waste. Initial drafts of the first coronavirus stimulus package – an $8.3 billion spending bill Congress passed March 4 – included a provision that would have allowed the government to dictate the price of any COVID-19 vaccine developed using federal funds.The price controls

Continue To Full Article